CareDx, Inc., based out of Brisbane, California, is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions.
www.caredx.com
AlloSure is the first and only, clinically and analytically validated, non-invasive test that assesses organ health by directly measuring allograft injury. AlloSure can accurately determine active rejection, enabling better management of your kidney transplant patients. AlloSure is covered by Medicare.
www.allosure.com
Brands: AlloSure
www.allosure.com